scispace - formally typeset
S

Shaban A. Khaled

Researcher at University of Nottingham

Publications -  7
Citations -  1443

Shaban A. Khaled is an academic researcher from University of Nottingham. The author has contributed to research in topics: Dissolution testing & Controlled release. The author has an hindex of 7, co-authored 7 publications receiving 1105 citations.

Papers
More filters
Journal ArticleDOI

3D printing of five-in-one dose combination polypill with defined immediate and sustained release profiles.

TL;DR: 3D extrusion printing was used to manufacture a multi-active solid dosage form that showed the intended immediate and sustained release profiles based upon the active/excipient ratio used and demonstrates that complex medication regimes can be combined in a single personalised tablet.
Journal ArticleDOI

Desktop 3D printing of controlled release pharmaceutical bilayer tablets.

TL;DR: The printed formulations were evaluated for physical and mechanical properties such as weight variation, friability, hardness and thickness as a comparison to the commercial tablet and were within acceptable range as defined by the international standards stated in the United States Pharmacopoeia (USP).
Journal ArticleDOI

3D printing of tablets containing multiple drugs with defined release profiles.

TL;DR: This 'polypill' made by a 3D additive manufacture technique demonstrates that complex medication regimes can be combined in a single tablet and that it is viable to formulate and 'dial up' this single tablet for the particular needs of an individual.
Journal ArticleDOI

3D extrusion printing of high drug loading immediate release paracetamol tablets.

TL;DR: The manufacture of immediate release high drug loading paracetamol oral tablets was achieved using an extrusion based 3D printer from a premixed water based paste formulation and showed a profile characteristic of the immediate release profile as intended based upon the active/excipient ratio.
Journal ArticleDOI

Extrusion 3D Printing of Paracetamol Tablets from a Single Formulation with Tunable Release Profiles Through Control of Tablet Geometry

TL;DR: The ability to use a single unmodified formulation to achieve defined release profiles could allow, for example, relatively straightforward personalization of medicines for individuals with different metabolism rates for certain drugs and hence could offer significant development and clinical opportunities.